Jim Simons’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Other funds holding LXEO
Jim Simons's LXEO Position: Q2 2026 in Review
Jim Simons opened a new position in Lexeo Therapeutics (LXEO) in Q2 2026: 250,365 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #2238 among its holdings. This is a return to the name: Jim Simons previously reported a position in LXEO as recently as Q4 2025.
Jim Simons first reported a position in LXEO in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.16M in Q4 2025. 141 funds tracked by Wall St. Rank hold LXEO as of Q2 2026.
- Jim Simons held 250,365 shares of Lexeo Therapeutics worth $1.17M as of Q2 2026.
- Lexeo Therapeutics was a new Jim Simons position in Q2 2026.
- Lexeo Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2238 holding.
- Jim Simons first reported a position in Lexeo Therapeutics in Q1 2024 and has held it in 6 quarters since.
- Jim Simons's Lexeo Therapeutics position peaked at $2.16M in Q4 2025.
- 141 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.